{"name":"Immune Targeting Systems Ltd","slug":"immune-targeting-systems-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":3,"colorKey":"oncology","drugs":[{"name":"FP-01.1","genericName":"FP-01.1","slug":"fp-01-1","indication":"Other","status":"phase_1"},{"name":"FP-01.1-Adjuvant","genericName":"FP-01.1-Adjuvant","slug":"fp-01-1-adjuvant","indication":"Other","status":"phase_1"},{"name":"Vaccine FP-01.1","genericName":"Vaccine FP-01.1","slug":"vaccine-fp-01-1","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"FP-01.1","genericName":"FP-01.1","slug":"fp-01-1","phase":"phase_1","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"FP-01.1-Adjuvant","genericName":"FP-01.1-Adjuvant","slug":"fp-01-1-adjuvant","phase":"phase_1","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"Vaccine FP-01.1","genericName":"Vaccine FP-01.1","slug":"vaccine-fp-01-1","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMijwFBVV95cUxOVElpSC0wMjhDc25ibXZ1bUhQY1M4Y3U3ckZhckU0ZFoxWlVVUnNWWFhXSU1rVm9WczgxcnM3T3czeHdPV0JGaWNzUmZ5dC1ZUll0TmJFczlWcnpLV3FiQnJtOENkVVVvUTZJQW9VTXNRMlVVcm5LSnI3a1poaXZLV3FvSmVaSmdVS25pT2JsZw?oc=5","date":"2026-03-25","type":"pipeline","source":"NYU Langone Health","summary":"Pinpointing New Cancer Targets for the Immune System’s Strike Force - NYU Langone Health","headline":"Pinpointing New Cancer Targets for the Immune System’s Strike Force","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixAFBVV95cUxOdFRBVkg2R0Z2WTZDdlZxTVZ1QTQ1OHh4Y18xMDNydmNCLWh4TUstdlFJOXJuVDBWSzFyQmNtYThTLXYtZ0lkWHN0WkVVQXU3RFMyRmpUZ1JNaUd5NThTQ1pTSDR3MmM1bHFWa2xUNjdUR2dMUXpsMkRZLXZXci05Sno0aGh4UmRuUkJmVVVKVURodmp4dWM5NmhhTTNVbjFaTFpVOXp1Y3AwT0J2NFNMSzliR1g3MzJHOElsbWtHRjdIelZ2?oc=5","date":"2026-02-10","type":"deal","source":"Genetic Engineering and Biotechnology News","summary":"Beyond Obesity: Lilly Inks Up to $11.25B in Cancer, Immune System Deals - Genetic Engineering and Biotechnology News","headline":"Beyond Obesity: Lilly Inks Up to $11.25B in Cancer, Immune System Deals","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxNR2VzcVJEN1NiSXh3WHR2Zi1GeHVOa252YnJqcWVjTEkyUWJiSWdHR1N2UlhTX3ZDZGRjRktMYkJqT3pUU3dVMzIydGhUOURkb0xYMGlEcGtobk1MLWtKSFlub043RXJuWmZRakVnRmhXMVM1TjBVRVRnYVBqNFdWaTJrNVZtUTBBSVhGcm5MUG0?oc=5","date":"2026-01-20","type":"pipeline","source":"PharmTech.com","summary":"Proteasomes: A Novel Approach to Target the Immune System - PharmTech.com","headline":"Proteasomes: A Novel Approach to Target the Immune System","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxOMm5hY1JNOVYydlhsSnU3VlJfUVlveHc5bkJOcjRub3QxZ0tWLVlWOFVIUVdjMmcxcHJhLVJtUk5yTDBJbWVKTjhFNUFBNnBORkt1elpHamE1aExoTVkzcUIyZkRaV1FqVXQ4Y2tUd1hlM2o1QW5kWXZOamc3WW9PaDN0NS1PVFpJUUVWeEFlenJaS3dRd1EzUVd6Ul9TYzRhZFIw?oc=5","date":"2026-01-06","type":"pipeline","source":"University of Houston","summary":"UH Pharmacy Researcher Awarded $900K CPRIT Grant for Cancer Nanodrug - University of Houston","headline":"UH Pharmacy Researcher Awarded $900K CPRIT Grant for Cancer Nanodrug","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE9JaHJ0WExWNW9lS2dQX3VfcnYtWGpoQldNT3FPMWQwdnpXMkJFYldtMk14TUhSM3M1OWVldVBPejBpV2J5VjJ2UEpFLWNEeHdtMnB2RjVyUndVOWgwNkcw?oc=5","date":"2025-12-09","type":"pipeline","source":"nature.com","summary":"Turning award-winning science into therapies - nature.com","headline":"Turning award-winning science into therapies","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiigFBVV95cUxPYkk3ZkoxTndSc3d6Q2J4X29FeHFDbWlmV3E3NUx1aUJKUEJYU053NXgyTGExeGkxY1BrV2tCT0tuSmF1VFVJRjF3N2M4ajFHeTViSTNYVUl0MTJpeGRQTmtHTEx5SWZ5ZkhNWmJiSGFwWVpfcG5WYlA1XzJyYjNIMlUtSjhjT3JmQWc?oc=5","date":"2025-10-28","type":"pipeline","source":"BioPharma Dive","summary":"Zag Bio emerges with plans to treat immune disease by targeting the thymus - BioPharma Dive","headline":"Zag Bio emerges with plans to treat immune disease by targeting the thymus","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiaEFVX3lxTE1vX1lVNld4MDdVUm52azA1c2o3V01fZjhqRnlKOUlTSzR6dmstMmFGRGF4akkweFY0bTA0MldaUmRibVh1bk40aHM1ZFRfNlZrZTVlNHFTRXhZZmtLMDRNLUhKWWZoREUz?oc=5","date":"2025-10-16","type":"deal","source":"calcalistech.com","summary":"Immunai strikes $85M deal with AstraZeneca to develop new IBD drug target - calcalistech.com","headline":"Immunai strikes $85M deal with AstraZeneca to develop new IBD drug target","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxPLTRoemFGeUh4b1RmYXV6WFFCWXhNMWNJQ3BxYXZ3RkJtejdQWjZ4elRUZ0RDaXBrNU5OZGQ2MjdqU25hbzlIMUJ0ZjlYbmNpZkJYcjJwYUFTa3c0cl8tX21VaFB6RVlZbThWcVNPUEZWVFpjTXFzU0JIUWhtc3dfdXdVdWNLelBGMDhMZURzV1lmZGNvZ2NBR0k3eHUzeVk?oc=5","date":"2025-10-08","type":"pipeline","source":"BioPharma Dive","summary":"Venture firms pour $101M into a biotech using the brain to fix the immune system - BioPharma Dive","headline":"Venture firms pour $101M into a biotech using the brain to fix the immune system","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTFBRRHNmallLZkI4TWtVZnZWVVNSX1hveUp3dXFJZl94LVB0a0M4aVUyY2RkYVZYdjMtSnI4YXhyYjcxbjRublRVcVAtM0Iwb2dqdmFsS2hwN1R1SmU3YU53?oc=5","date":"2025-05-12","type":"pipeline","source":"nature.com","summary":"The race to reset autoimmune diseases - nature.com","headline":"The race to reset autoimmune diseases","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTFBlLU9IbzhNb2VXVGNGNjRNejRlb2x2ck14aFdVZHJPN25PMEpyV1JLV2VHR1lrUTNUQ0lxdVRqTUlLaXo3VUVWMElRYWJ3ZGdJNWZ1RkVhVHRzQlV3Y3Ew?oc=5","date":"2025-05-05","type":"pipeline","source":"nature.com","summary":"Rational development of gemcitabine-based nanoplatform for targeting SERPINB9/Granzyme B axis to overcome chemo-immune-resistance - nature.com","headline":"Rational development of gemcitabine-based nanoplatform for targeting SERPINB9/Granzyme B axis to overcome chemo-immune-r","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxQLWM4NDZiTVdDbUNHTldNNndrX3NpTW9JUzh0YjNZYjB3X2lmSkJZaTZpRVp4OHlQMUcwMFNNc0dJRUM2SUZwa1B3dXFFbTR0eGwyU2w5eFlIeFNvY1FMTElJVTgwQkVMaGc5elJDc3VkOUpmQWZRbVd1dS04dkc2aXlWeHplSEJmalkybjI2X0k?oc=5","date":"2024-02-11","type":"pipeline","source":"Frontiers","summary":"Cancer Vaccines, Adjuvants, and Delivery Systems - Frontiers","headline":"Cancer Vaccines, Adjuvants, and Delivery Systems","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijwFBVV95cUxOVGJqUGE3bVNVV2tLdEpqOXBVZERUX3FRYmVvcTdBazJwcnk3X3VPcE1WV195NDM5aC05X0xVWWNLa3I2bW1FYlVZcXdPQ05aM24xcnl6cjFub0tuU1EtNXAtY1dEWlE0ald3VVgxZXF5RjliMm1LRHlwU2FBV1ZpTTcza3VHQmpoWDJpZm9FUQ?oc=5","date":"2024-02-05","type":"pipeline","source":"Frontiers","summary":"Advances in Targeting the Innate and Adaptive Immune Systems to Cure Chronic Hepatitis B Virus Infection - Frontiers","headline":"Advances in Targeting the Innate and Adaptive Immune Systems to Cure Chronic Hepatitis B Virus Infection","sentiment":"neutral"}],"patents":[],"drugCount":3,"phaseCounts":{"phase_1":3},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}